New nasal spray aims to tame severe asthma Flare-Ups
Disease control
Not yet recruiting
This study is testing a new nasal spray called AD17002 for adults with a specific type of severe asthma that is not well managed by their current medications. The goal is to see if adding this spray to existing treatments is safe and can help reduce the frequency and severity of …
Phase: PHASE2 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC